drugset / Trial / NCT00630708
Safety of Dual Blockage of Rennin-angiotensin System in Patients With Advanced Renal Insufficiency
RandomizedParallel-groupOpen-labelTreatment
Summary
The primary aim of the present study is to assess the safety of combined treatment of benazepril (an ACE inhibitor) or losartan (an ARB) in non-diabetic patients with advanced renal insufficiency.
Timeline
- Start
- 2008-02
- Primary completion
- 2014-03
- Completion
- 2014-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Benazepril | Unknown | 10 mg | — |
| Comparator | Benazepril | Unknown | 20 mg | — |
| Comparator | Losartan | Other / unclassified | 50 mg | — |
| Comparator | Losartan | Other / unclassified | 100 mg | — |